HCR 34: Responsible Marijuana Research

[et_pb_section bb_built=”1″ _builder_version=”3.0.98″ custom_padding=”0px|0px|54px|0px”][et_pb_row custom_padding=”0px|0px|25px|0px” _builder_version=”3.0.47″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_image src=”https://www.kentuckyfamily.org/wp-content/uploads/2018/02/MarijuanaLeafGreen.jpg” _builder_version=”3.0.98″ max_width=”14%” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” always_center_on_mobile=”on” force_fullwidth=”off” show_bottom_space=”on” /][et_pb_text admin_label=”rep” _builder_version=”3.0.98″ background_layout=”light”]

Rep. Danny Bentley

[/et_pb_text][et_pb_text _builder_version=”3.0.98″ background_layout=”light”]

HCR 34 actually delays marijuana legalization, instead urging the expedited research and appropriate approval of marijuana derivatives for medical use. Bill sponsor, Dr. Bentley, a PhD, registered pharmacist and university faculty member explains that several marijuana derivatives are currently approved and available by prescription, with others likely to be legalized soon. He warns the legislature about circumventing the FDA to legalize a smoked plant unrefined for medical use that has over 600 components whose harms have not been adequately studied. Note: Other bills have been offered to legalize “medical” and recreational marijuana in Kentucky.

[/et_pb_text][et_pb_divider color=”#0c0c0c” show_divider=”on” _builder_version=”3.0.98″ max_width=”17%” /][et_pb_text admin_label=”pdf” _builder_version=”3.0.98″ background_layout=”light”]

Click to Read Full Bill Text – HCR 34

[/et_pb_text][et_pb_text admin_label=”pdf” _builder_version=”3.0.98″ background_layout=”light”]

Insight Into HCR 34

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

Leave a Reply